Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease

BACKGROUND: Proton pump inhibitors (PPIs) are frequently prescribed to patients with coronary heart disease (CHD) under antiplatelet therapy to prevent gastrointestinal (GI) bleeding. However, its clinical impact is still under debate, especially in Asian population. This study was undertaken to exp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cardiovasc Disord
Main Authors: He, Wanbing, Shu, Xiaorong, Zhu, Enyi, Deng, Bingqing, Lin, Yongqing, Wu, Xiaoying, Zhou, Zenan, Wang, Jingfeng, Nie, Ruqiong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863361/
https://ncbi.nlm.nih.gov/pubmed/33546595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-021-01884-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados